Kura Oncology KURA
NASDAQ KURA
$10.65 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Non Operating Interest Expenses (2010 - 2026)

Updated

Kura Oncology's Non Operating Interest Expenses was $345,000 in Q2 2026, down 11.8% from $391,000 a year earlier but up 2.7% from the prior quarter.

Analysis

Kura Oncology (KURA) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kura Oncology's Non Operating Interest Expenses was $1.42 million through Jun 30, 2026, down 10.6% year-over-year; for FY2025, it came in at $1.51 million, down 6.6% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $1.62 million in FY2024 (+4.5%), $1.55 million in FY2023 (+576.4%), $229,000 in FY2022 (-44.7%) and $414,000 in FY2021 (-28.4%).
  • Quarterly Non Operating Interest Expenses has moved between $336,000 (Q1 2026) and $412,000 (Q3 2024) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has declined for six straight quarters, with an average decline of 5.8% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q1 2024 (growth of 9.3%); the worst was Q4 2025 (a decline of 14.1%).
  • Per Business Quant data, KURA's Non Operating Interest Expenses in the three quarters before Q2 2026 was $336,000 (Q1 2026), $346,000 (Q4 2025) and $393,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 281.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -435.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 247.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kura Oncology 947.36 Mn 947.36 Mn 20.63 Mn 345,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 345,000.00
Mar 31, 2026 336,000.00
Dec 31, 2025 346,000.00
Sep 30, 2025 393,000.00
Jun 30, 2025 391,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 403,000.00
Sep 30, 2024 412,000.00
Jun 30, 2024 406,000.00
Mar 31, 2024 398,000.00
Dec 31, 2023 394,000.00
Sep 30, 2023 404,000.00
Jun 30, 2023 387,000.00
Mar 31, 2023 364,000.00
Jun 30, 2021 306,000.00
Mar 31, 2021 108,000.00
Dec 31, 2020 144,000.00
Sep 30, 2020 146,000.00
Jun 30, 2020 144,000.00
Mar 31, 2020 144,000.00
API Access

Kura Oncology Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KURA&period=max&api_key=YOUR_API_KEY